Forest Laboratories Inc. announced on March 20 to have received FDA approval of its depression and anxiety drug Lexapro (escitalopram oxalate) for use in children between the ages of 12 and 17 years old. In February the Justice Department filed a complaint against Forrest for marketing its drugs Lexapro and Celexa (citalopram hydrobromide) for use by children, even though they were not approved for this age group. The company expressed gratitude for having received the FDA approval for adolescents use.